Stocks

Ginkgo Bioworks Holdings DNA

Health care sectorNYSE

What to see in Ginkgo Bioworks Holdings now

Who bought more than 5%?7.7%

BlackRock holds 7.7% · +1.2pp on the report before

Filed 07/30
Is Wall Street adding or cutting?+8

183 13F filers hold it · +8 against the quarter before · shares held +11.9%

Holdings of 06/30
Is stock about to come to market?$51.4K

$51.4K of planned sales filed in 30 days · under 0.1% of the units outstanding

Filed 09/17

Company

Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Boston, Massachusetts
Fiscal year end
12/31
Next earnings
11/04, estimated
  • 1 members of the National Assembly hold it · +0 on the year beforePublished 24/03/28

Korean lawmakers

Korean Assembly members holding Ginkgo Bioworks Holdings in the 2024 disclosure.

MemberSharesFrom last year
양이원영더불어시민당 · 비례대표1,500 sh+1,350 sh

Members holding it by year: 2023: 1 · 2024: 1

Korean lawmakers' US stocks

26-week trading